Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Hayes

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Circulation|November 25, 2010
Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival studyLeslie A Saxon, David L Hayes, F Roosevelt Gilliam, et al.
The American Journal of Cardiology|January 2, 2013
Predictors of mortality in patients with cardiovascular implantable electronic device infectionsAmmar Habib, Katherine Y Le, Larry M Baddour, et al.
Journal of Cardiovascular Electrophysiology|September 15, 2011
Cardiac resynchronization therapy: do women benefit more than men?Yi-Zhou Xu, Paul A Friedman, Tracy Webster, et al.
Circulation|May 14, 2008
Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left bundle-branch blockChinami Miyazaki, Brian D Powell, Charles J Bruce, et al.
Circulation|January 19, 2011
Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient managementRobert G Hauser, William H Maisel, Paul A Friedman, et al.
Journal of Cardiovascular Electrophysiology|August 22, 2003
Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictorsOsnat T Gurevitz, Paul A Friedman, Michael Glikson, et al.
Journal of the American College of Cardiology|May 8, 2007
Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infectionsMuhammad R Sohail, Daniel Z Uslan, Akbar H Khan, et al.
Heart Rhythm|September 1, 2009
Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survivalAnita Wokhlu, Robert F Rea, Samuel J Asirvatham, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 7, 2014
Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patientsLaTonya J Hickson, Janelle Y Gooden, Katherine Y Le, et al.
Journal of the American College of Cardiology|July 2, 2013
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm studyBrian D Powell, Leslie A Saxon, John P Boehmer, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Circulation|November 25, 2010
Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival studyLeslie A Saxon, David L Hayes, F Roosevelt Gilliam, et al.
The American Journal of Cardiology|January 2, 2013
Predictors of mortality in patients with cardiovascular implantable electronic device infectionsAmmar Habib, Katherine Y Le, Larry M Baddour, et al.
Journal of Cardiovascular Electrophysiology|September 15, 2011
Cardiac resynchronization therapy: do women benefit more than men?Yi-Zhou Xu, Paul A Friedman, Tracy Webster, et al.
Circulation|May 14, 2008
Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left bundle-branch blockChinami Miyazaki, Brian D Powell, Charles J Bruce, et al.
Circulation|January 19, 2011
Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient managementRobert G Hauser, William H Maisel, Paul A Friedman, et al.
Journal of Cardiovascular Electrophysiology|August 22, 2003
Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictorsOsnat T Gurevitz, Paul A Friedman, Michael Glikson, et al.
Journal of the American College of Cardiology|May 8, 2007
Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infectionsMuhammad R Sohail, Daniel Z Uslan, Akbar H Khan, et al.
Heart Rhythm|September 1, 2009
Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survivalAnita Wokhlu, Robert F Rea, Samuel J Asirvatham, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 7, 2014
Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patientsLaTonya J Hickson, Janelle Y Gooden, Katherine Y Le, et al.
Journal of the American College of Cardiology|July 2, 2013
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm studyBrian D Powell, Leslie A Saxon, John P Boehmer, et al.
Pageof 15